跳至主要内容
临床试验/JPRN-UMIN000022561
JPRN-UMIN000022561已完成未知

Investigation of the visceral fat and adipocytokine by SGLT2 inhibitors in type 2 diabetes millitus - Impact on the visceral fat and adipocytokine by SGLT2 inhibitors

Dokkyo medical university, Endocrinology and Metabolism0 个研究点目标入组 60 人开始时间: 2016年6月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Type 1 diabetes, secondary diabetes 2.Severe ketosis, diabetic coma, or before coma 3.Severe infection, before and not long after surgery, or patients with severe trauma 4.Severe cerebrovascular dysfunction, heart disorder, renal dysfunction and liver dysfunction 5.Heart failure(NYHA classification 3-4), patients treated by diuretic 6.Patients who have repeated urinary tract infections 7.Alchole intake excessive 8.Women suspected of pregnancy or pregnant 9.Patients with a history of use SGLT2 inhibitors

研究者

发起方
Dokkyo medical university, Endocrinology and Metabolism

相似试验